Novo Nordisk: Actual Numbers Not As Good As Headlines But Still Quite Solid [Seeking Alpha]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Seeking Alpha
Novo Nordisk: Actual Numbers Not As Good As Headlines But Still Quite Solid Summary Novo Nordisk's growth was not quite as strong as the headline numbers would make you think, since a weakening Danish krone accounted for some of it. The company saw its flagship GLP-1 analogue continue to make impressive market share gains in both North America and Europe. The company now has another blockbuster drug on its hands. It is not resting on its laurels and has just received FDA approval to market semaglutide as a tablet, a first for a GLP-1 analogue. The company will likely continue to prosper as diabetes becomes an ever-greater health concern around the world. On Friday, November 1, 2019, diabetes-focused pharmaceutical giant Novo Nordisk A/S ( NVO announced As my long-time readers are no doubt well aware, it is my usual practice to share the highlights from a company's earnings report before delving into an analysis of its results. This is because these highlights provide a background for
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Yahoo Finance [Yahoo! Finance]Yahoo! Finance
- Pound slumps to lowest level in four months [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk A/S (NVO) Trembled At The End Of The Quarter [Yahoo! Finance]Yahoo! Finance
- Dr. Sanjay Gupta: Blockbuster weight loss drugs are revealing what we still don't understand about obesity [CNN]CNN
- Dr. Sanjay Gupta: Blockbuster weight loss drugs are revealing what we still don't understand about obesity [CNN]CNN
NVO
Earnings
- 11/7/24 - Beat
NVO
Sec Filings
- 11/14/24 - Form 6-K
- 11/13/24 - Form 6-K
- 11/8/24 - Form 6-K
- NVO's page on the SEC website